News | Breast Imaging | July 16, 2021

Volpara now holds 98 granted patents across 27 countries

Volpara now holds 98 granted patents across 27 countries

July 16, 2021 — Volpara has recently been granted another patent by the European Patent Office, raising the total number of patents for the New Zealand-based health tech company to 98. This latest patent, effective across 25 European countries, outlines the Volpara method of image quantification, used in multiple instances across the Volpara Breast Health Platform product suite.

This latest patent highlights improved analysis of several quantitative measures from low dose images, enabling highly accurate assessment of a woman's breast composition at an early age, and calculation of her baseline risk of breast cancer. In addition to improving outcomes for women, the improvements will help optimize clinical workflow.

Research studies are beginning to suggest patients receive a baseline mammogram to assess their breast density and breast cancer risk before they reach the screening age of 40. A patient who receives a high breast cancer risk score may be directed to begin annual screenings earlier than usual.

One of the concerns with offering women between the ages of 25 and 30 a baseline screening exam has been the effect of the exam's radiation. High-sensitivity, low-dose imaging has the potential to offer patients a way around this issue — a solution in line with Volpara's aim to achieve personalized breast cancer screening for all women.

"Securing our 98th patent is another major step forward for the company, re-affirming our position as a leading innovator in the medical imaging space, and a testament to our R&D team who are constantly pushing the boundaries in novel and important directions, ever seeking to improve the early detection of cancer," said Volpara Health CEO Ralph Highnam.

This patent, together with the entire Volpara patent portfolio, serves to protect all the company's products. In sum, these patents are effective across 27 countries, including most of Europe, the US, and China.

"These patents work together with Volpara's other international intellectual property rights to facilitate the sales and growth strategy for Volpara's product line, including software geared toward patient reporting and communication, image/exam quality monitoring and feedback, and automated breast density calculations, as well as a full risk program," said Volpara Health CFO Craig Hadfield.

Early cancer detection is key to fulfilling the Volpara mission to eliminate late-stage breast cancer and save families from cancer.

For more information: www.volparahealth.com

Related Content

News | Radiology Education

August 9, 2022 — SBI is pleased to invite all members and nonmembers to submit original abstracts for presentation at ...

Time August 11, 2022
arrow
News | Ultrasound Women's Health

August 10, 2022 — TransMed7, LLC announced that the first clinical cases of the final commercial production version of ...

Time August 10, 2022
arrow
News | Breast Imaging

July 28, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), for patients with multiple architectural ...

Time July 28, 2022
arrow
News | Mammography

July 28, 2022 — The National Comprehensive Cancer Network (NCCN) has published new NCCN Guidelines for Patients: Breast ...

Time July 28, 2022
arrow
News | Breast Imaging

July 26, 2022 — Seno Medical’s Imagio Breast Imaging System, a revolutionary new modality in breast imaging, has ...

Time July 26, 2022
arrow
News | Breast Imaging

July 21, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), understanding the likelihood of malignancy ...

Time July 22, 2022
arrow
Feature | Radiology Business

View the July/August digital edition of Imaging Technology News (ITN), including links to videos, comparison charts and ...

Time July 21, 2022
arrow
News | Breast Density

July 19, 2022 — DenseBreast-info.org (DB-i) has completed a health literacy update of patient educational materials on ...

Time July 19, 2022
arrow
News | Breast Imaging

July 18, 2022 — Hologic, Inc. will showcase their comprehensive portfolio of breast and skeletal health solutions at the ...

Time July 19, 2022
arrow
Feature | Breast Imaging | By Christine Book

In a detailed overview held during the Radiological Society of North America’s (RSNA) 2021 annual meeting, promising ...

Time July 08, 2022
arrow
Subscribe Now